(NASDAQ: IART) Integra Lifesciences Holdings's forecast annual revenue growth rate of 7.42% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.89%.
Integra Lifesciences Holdings's revenue in 2025 is $1,564,920,000.On average, 6 Wall Street analysts forecast IART's revenue for 2025 to be $132,169,773,574, with the lowest IART revenue forecast at $131,116,259,981, and the highest IART revenue forecast at $132,744,564,664. On average, 5 Wall Street analysts forecast IART's revenue for 2026 to be $138,221,014,290, with the lowest IART revenue forecast at $137,860,351,978, and the highest IART revenue forecast at $138,763,165,209.
In 2027, IART is forecast to generate $149,782,116,436 in revenue, with the lowest revenue forecast at $149,782,116,436 and the highest revenue forecast at $149,782,116,436.